Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 August 2006, Vol. 108, No. 4, pp. 1395-1401.
Prepublished online as a Blood First Edition Paper on April 27, 2006; DOI 10.1182/blood-2006-04-014431.


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-014431v1
108/4/1395    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bender, M. A.
Right arrow Articles by Groudine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bender, M. A.
Right arrow Articles by Groudine, M.
Related Collections
Right arrow Red Cells
Right arrow Gene Expression
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RED CELLS

Flanking HS-62.5 and 3' HS1, and regions upstream of the LCR, are not required for beta-globin transcription

M. A. Bender, Rachel Byron, Tobias Ragoczy, Agnes Telling, Michael Bulger, and Mark Groudine

From the Divisions of Clinical Research and Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; Departments of Pediatrics and Radiation Oncology, University of Washington, Seattle, WA; and the Center for Pediatric Biomedical Research and Department of Biochemistry and Biophysics, University of Rochester, NY.


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The locus control region (LCR) was thought to be necessary and sufficient for establishing and maintaining an open beta-globin locus chromatin domain in the repressive environment of the developing erythrocyte. However, deletion of the LCR from the endogenous locus had no significant effect on chromatin structure and did not silence transcription. Thus, the cis-regulatory elements that confer the open domain remain unidentified. The conserved DNaseI hypersensitivity sites (HSs) HS-62.5 and 3'HS1 that flank the locus, and the region upstream of the LCR have been implicated in globin gene regulation. The flanking HSs bind CCCTC binding factor (CTCF) and are thought to interact with the LCR to form a "chromatin hub" involved in beta-globin gene activation. Hispanic thalassemia, a deletion of the LCR and 27 kb upstream, leads to heterochromatinization and silencing of the locus. Thus, the region upstream of the LCR deleted in Hispanic thalassemia (upstream Hispanic region [UHR]) may be required for expression. To determine the importance of the UHR and flanking HSs for beta-globin expression, we generated and analyzed mice with targeted deletions of these elements. We demonstrate deletion of these regions alone, and in combination, do not affect transcription, bringing into question current models for the regulation of the beta-globin locus.


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The beta-globin locus remains a paradigm for vertebrate gene expression, as it contains multiple genes that are highly expressed in a tissue and developmentally specific manner, is highly conserved through evolution, and is a target for mutations affecting hundreds of thousands of patients worldwide.1 Despite intensive study, little is known of how the beta-globin locus becomes and remains activated in the repressive environment of a differentiating erythroid nucleus. The transcriptional silencing of the human beta-globin locus by naturally occurring deletions far upstream of the beta-like globin gene cluster ({gamma}{delta}beta thalassemias) suggested that this region contained regulatory elements capable of activating gene expression and/or protecting genes from the dramatic heterochromatinization that occurs during erythroid maturation.2-5 In particular, a deletion of 39.5 kb upstream of the beta-globin genes, called the Hispanic deletion, results in profound alterations, including acquiring a DNaseI-resistant chromatin structure, changes in replication origin use and timing, and silencing of transcription.3,4,6

Analysis of beta-globin transgenes in mice led to the identification of a regulatory element lying within this large deletion, the locus control region (LCR), defined by its ability to drive transgene expression at high and relatively consistent levels at nearly all genomic integration sites.7,8 This activity was long taken to suggest that the LCR was capable of counteracting the repressive effects of chromatin structure at different regions of the genome.1,9,10 Thus, it was thought that in addition to driving high-level gene expression, the LCR was necessary for the establishment of an "open" chromatin domain, as defined by DNaseI sensitivity and epigenetic modifications, such as histone acetylation, that are typically associated with active gene loci. However, targeted deletion of the endogenous mouse or human beta-globin LCR resulted in a large decrease in beta-globin gene expression, but failed to elicit any significant alterations in chromatin structure.11-13 Thus, in its native location, the sole essential function of the LCR is that of an enhancer of transcription, raising the question of what cis-acting sequences in the locus are essential for the initiation and maintenance of an open, active chromatin domain. As the Hispanic thalassemia deletion exhibits significant changes in chromatin structure, and since it removes an additional 27.5 kb of DNA upstream of the LCR, this upstream Hispanic region (UHR) represents a logical candidate for such a cis-acting sequence.

Two additional candidates for cis-acting elements regulating the chromatin structure and organization of the locus are the erythroid-specific DNaseI hypersensitive sites (HSs) located both upstream of the LCR (HS-62.5) and downstream of the beta-globin genes (3'HS1).14-16 Studies using the chromatin conformation capture (3C) technique have led to a model in which these 2 regions and the 5' end of the LCR interact to create an erythroid-specific, developmentally stable nuclear compartment designated the "chromatin hub" (CH) important for activation of beta-like genes.17-20 Notably, all 3 regions are bound by CCCTC binding factor (CTCF), and 5'HS5 and 3'HS1 have been shown to function as CTCF-dependent enhancer-blocking elements when placed between enhancers and promoters.15,16 While the full spectrum of CTCF activities has not been elucidated, CTCF-dependent enhancer-blocking activity is a hallmark of some "boundary" elements that are believed to organize gene loci in eukaryotic genomes.21,22 Studies in yeast and Drosophila have led to models in which boundary elements anchor an intervening domain to a nuclear scaffold, isolating the domain from the effects of neighboring loci.23,24 Thus, cis-acting sequences (such as the LCR) within the flanked region would lead to epigenetic modifications permissive for full gene activation, while the flanking boundary elements define the extent of the modified domain and prevent interaction with surrounding regions. The paradigm for vertebrate systems is the chicken beta-globin locus, flanked by c5'HS4 and c3'HS, which both bind CTCF in erythroid cells and demarcate sharp boundaries between the "open" DNaseI-sensitive locus, characterized by hyperacetylated core histones, and the flanking regions of DNaseI-resistant heterochromatin.25-28 While both HSs demonstrate CTCF-dependent enhancer-blocking activity at ectopic sites, cHS4 can protect randomly integrated reporter genes from silencing, and this activity is dependent on the binding of upstream stimulatory factor (USF) proteins.21,22,28-32 While the role of the flanking HSs at the endogenous locus in chickens has not been determined, it is hypothesized that these flanking HSs protect the locus from the spread of heterochromatin and transcriptional silencing, which may be particularly critical during terminal differentiation. Notably, the structural organization of the mouse and human beta-globin loci is similar to that of chickens in that the LCR and genes are flanked by HSs that bind CTCF (HS-62.5 and 5'HS5 upstream, and 3'HS1 downstream).15,16,33

To determine the importance of the UHR and flanking HSs on beta-globin gene expression at the endogenous locus, and to apply this to models of beta-globin locus activation and organization, we have generated and analyzed several strains of mice in which these elements have been eliminated from the mouse beta-globin locus by targeted deletion. To facilitate this analysis we have derived and validated the use of 2 embryonic stem (ES) cell lines heterozygotic for the beta-globin locus that allow internally controlled experiments after in vitro differentiation. Using these cell lines, and mice generated from them, we show these regions alone, and in combination, do not affect transcription of genes in the locus, bringing into question current models for the regulation of the beta-globin locus.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Generation and screening of mutant mice

Targeted deletions of the HS-62.5 and 3'HS 1 regions and generation of mice were performed as described34,35 using LoxP-flanked PGK–neomycin phosphotransferase (NPT) or hygromycin cassettes and either D/S-2B or {Delta}LCR-D/S-1 ES cells (described in "Results"). These deletions remove nucleotides –63238 through –59669 and 66666 through 67467 relative to the Ey cap site, respectively. In each case the deletion removes the CTCF binding HS as well as other associated HSs. Cre-mediated excision of selectable markers and of the UHR was done by transient expression of the Cre recombinase followed by screening for clones with the desired structure.

RT-PCR assays

RNA isolation, reverse transcriptase–polymerase chain reaction (RT-PCR), and quantitation were done as described previously,35,36 with the following exception. For in vivo analysis flow cytometry sorted 100 cell pools of adult reticulocytes, or embryonic red blood cells (RBCs) were analyzed as described for our single-cell assay. For reticulocytes, a 1-step RT-PCR with 8 cycles was followed by a 20-fold dilution and radioactive PCR for an additional 16 cycles. In all cases we determined that PCR amplification was in the linear range, and no heteroduplex formation was detectable. For stress erythropoiesis studies spleen and blood bulk RNA was isolated while animals were recovering from a phenylhydrazine-induced anemia.27,34 Pools of sorted cells were not analyzed because phenylhydrazine-induced autofluorescence interferes with flow cytometry.

DNaseI hypersensitivity site mapping

Nuclei were isolated from spleens of mice during recovery from a phenylhydrazine-induced hemolytic anemia, at which time at least 75% of cells are erythroid.27,34 Phenylhydrazine treatment and DNaseI digestion were done as described.27,34 DNA was digested with EcoRV and hybridized with probes spanning from –54700 to –53803, 69993 to 70253, and –21222 to –20508 relative to the Ey cap for examining the HS-62.5, 3'HS1, and 5'HS4 regions, respectively.

Primary transcript FISH

Fetal liver cells from mice on day 13.5 after conception were simultaneously stained with TER-119,37 ERY-1,38 and anti-CD117 monoclonal antibodies.39 CD-117, ERY-1, TER-119+ cells consisting of nucleated RBCs with some orthochromatic normoblasts, and RBCs were isolated by flow cytometry and subjected to primary transcript RNA fluorescent in situ hybridization (FISH) as described.39


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Establishment of HbbD/HbbS (D/S) heterozygotic ES cell lines

To facilitate the analysis of targeted mutations of the endogenous murine beta-globin locus after in vitro differentiation, we generated 2 ES cell lines heterozygotic for the HbbD (D) and HbbS (S) alleles. After targeting the D allele RT-PCR, 3C and chromatin immunoprecipitation (ChIP) assays exploiting polymorphisms can be used to quantitatively determine the effect of the mutation when compared to a wild-type (WT) S allele in the same cell. The S allele from C57 mice, and the X-linked mutant Hprt gene from mice derived from BK4 ES cells40 were back-crossed onto a 129 background. Male 129 mice carrying a deletion of the endogenous LCR ({Delta}LCR-D/WT-D, Hprt+/0) were bred with 129 WT-S/WT-S Hprt–/– dams, and ES cell lines were generated from the resulting blastocysts using standard techniques.41 Genotype, karyotype, disomy for chromosome 8, and the potential to give good germ-line transmission were confirmed. Two lines were expanded for future use. D/S-2B cells are WT-D/WT-S, Hprt+/0 male cells. {Delta}LCR-D/S-1 cells are identical but contain the {Delta}LCR-D allele described previously instead of the WT-D allele.

Deletion of the UHR and HS-62.5 regions

To determine whether the UHR and/or HS-62.5 element are required for the establishment or maintenance of an open, active chromatin domain and responsible for the residual transcriptional activity of the locus in the absence of the LCR, we generated 2 ES cell lines containing mutant alleles. {Delta}LCR-D/S-1 ES cells were targeted with a vector to replace the HS-62.5 region with a NPT gene flanked with lox sites. Restriction fragment–length polymorphism (RFLP) analysis revealed the D allele was correctly targeted; thus, this deletion is in cis to the LCR deletion (data not shown). Of note, a single lox site is present at the site of the LCR deletion. To avoid any effect of the selectable marker, and to excise the UHR, Cre recombinase was transiently expressed in ES cells and the structure of G418 sensitive clones was analyzed. Two types of mutant alleles were isolated and used for further analysis. Cre-mediated recombination between the far upstream and the LCR Lox P sites led to {Delta}HS-62.5 -> LCR D/S cells that carry a deletion from –63238 to –2069 relative to the Ey cap (Figure 1). This allele lacks the LCR, HS-62.5, and all intervening sequences, which includes the UHR. If this extension of the LCR deletion led to silencing of the locus, it could be secondary to the loss of the UHR or the HS-62.5 region. To distinguish between these possibilities, we identified {Delta}HS-62.5, {Delta}LCR D/S clones that lack the LCR and HS-62.5 region but have an intact UHR on the D allele.


Figure 1
View larger version (16K):
[in this window]
[in a new window]
 
Figure 1.. Map of mutant D alleles generated by homologous recombination. (A) Map of the mouse beta-globin locus. Arrowheads represent genes. Vertical arrows represent HSs. ORG indicates olfactory receptor gene. The extent of the DNaseI-sensitive domain is diagrammed below the locus map. (B) Diagrammatic representations of the targeted deletions generated. Striped region designates the UHR, the region upstream of the LCR that has homology to the region deleted in the Hispanic deletion.

 
The UHR is not essential for transcription in vitro

To determine the effects of the UHR and upstream HSs on transcription, {Delta}HS-62.5 -> LCR/S and {Delta}HS-62.5, {Delta}LCR/S ES cells were induced to differentiate to the erythroid lineage in a semisynchronous manner on OP9 feeder cells.42 Bulk RNA was analyzed by quantitative RT-PCR assays that exploit RFLPs between the D and S alleles in order to determine allele-specific expression. For both cell lines the mutant D allele was expressed at 1% to 8% of the WT S allele (data not shown). This was true for the embryonic Ey and bH1 globin genes as well as the adult genes, and is similar to what we observed for the deletion of the LCR alone in vitro and in vivo. Thus, in vitro, additional deletion of the UHR and/or HS-62.5 region does not significantly alter transcription when compared to the deletion of the LCR alone.

Deletion of the LCR and UHR does not recapitulate the Hispanic thalassemia phenotype in vivo

Differentiation in vitro may not faithfully recapitulate all epigenetic modifications that occur with passage through the germ line and normal development. To determine if the UHR and upstream element are necessary to prevent silencing of the beta-globin locus after passage through the germ line, {Delta}HS-62.5 -> LCR/S and {Delta}HS-62.5, {Delta}LCR/S ES cells were used to generate mice heterozygous for the mutant D allele and a WT S allele. For both strains the ratio of expression from the mutant adult beta-globin genes to that from the WT allele was 4%, almost identical to that from the LCR mutation alone36 (Figure 2; Table 1). In theory, deletion of a boundary element or a domain-activating element could lead to variegated expression, with a subpopulation of mutant alleles being silenced. Heterochromatinization is known to exhibit stochastic behavior, resulting in the variegated expression of genes. Therefore, we examined beta-globin gene expression by RT-PCR analysis of individual reticulocytes from each mouse line. Variegation was not evident in samples derived from any of the mutant mouse lines, as each cell expressed beta-globin at the same low levels (Table 1) and no silenced or high-expressing alleles were found. Thus, in the context of a deleted LCR, we find no contribution of the UHR or upstream HS and CTCF site on the level or probability of expression. We demonstrate that deletion of the LCR, UHR, and upstream HS-62.5 element does not recapitulate the Hispanic thalassemia phenotype. In addition, these elements are not necessary for basal levels of expression, and thus are not required for the establishment or maintenance of an active chromatin domain.


View this table:
[in this window]
[in a new window]
 
Table 1.. Adult beta-globin expression measured in the peripheral blood of heterozygotic animals

 
The HS-62.5 and 3'HS1 regions have no effect on transcription

The CTCF-binding elements HS-62.5 and 3'HS1 that flank the beta-globin locus have been implicated in the regulation of an active chromatin domain. Support for this is derived from 3C studies that suggest these regions interact prior to activation of the locus, as well as orthology to the chicken locus.15,17,18,20,33 To determine the effects of the flanking HSs on transcription and to test the model that the ends of the locus must colocalize in a functionally significant way to define the ends of an active domain and mediate gene activation, we generated ES cells with targeted deletions of the HS-62.5 region and 3'HS1 individually and in combination (Figure 1). All mutations were made on the D allele of D/S-2B cells.

Despite loss of both flanking HSs, no alteration in transcription of the adult genes was noted after erythroid differentiation of mutant ES cells (data not shown). To confirm this in vivo, ES cells were used to generate heterozygotic mice, and the ratio of expression from the mutant D allele to the WT S allele in pools of 100 reticulocytes was determined (Figure 2; Table 1). Deletion of each region alone, or in combination, did not result in significant alteration of adult gene expression. Analysis of allele-specific expression in individual reticulocytes showed homogeneous levels of expression that were identical to WT, and no nonexpressing alleles were noted (Table 1). In addition, hematologic analysis of adult mice homozygous for the deletion of both flanking HSs ({Delta}HS-62.5 and {Delta}3'HS1) reveals a normal hematocrit, reticulocyte count, and cell size, demonstrating that overall hemoglobin production is not affected (Table 2). Thus, the flanking HSs of the beta-globin locus are not needed for full expression of the beta-like genes in the context of an intact chromosome in vitro or in vivo.


View this table:
[in this window]
[in a new window]
 
Table 2.. Red-cell indices of WT and homozygous {Delta}HS-62.5, {Delta}3'HS1 mice

 


Figure 2
View larger version (30K):
[in this window]
[in a new window]
 
Figure 2.. Expression of the adult beta-globin genes in mice heterozygous for targeted deletions. The HbbD allele (D) carries the targeted mutation, while the HbbS allele (S) is wild-type. Pools of 100 reticulocytes were isolated from peripheral blood by flow cytometry and analyzed by RT-PCR with primers that amplify both adult genes from both alleles. Analysis of 2 representative independent pools is shown for each mouse strain. WT indicates wild-type D/S animals. Other strain designations are described in "Results." S and D mark the RT-PCR product from the S and D alleles, respectively.

 
As adult beta-globin gene expression is not altered from the mutant {Delta}HS-62.5, {Delta}3'HS1 allele in heterozygotes, we tested several hypotheses for the role of these conserved HSs. If, as hypothesized for the chicken locus, the flanking HSs function to prevent the spread of a heterochromatic state into the locus, resulting in gene silencing, we would expect to see the largest decrease in active transcription from {Delta}HS-62.5, {Delta}3'HS1 allele, compared with WT, in the most mature nucleated erythroid cells. To directly test this, nucleated RBCs and orthochromatic normoblasts were isolated from fetal liver by flow cytometry and subjected to primary transcript FISH using oligonucleotide probes specific to the adult beta-major gene introns.39 This population represents approximately 5% of total fetal liver cells. No significant difference in the number of actively transcribing alleles was observed between the nucleated RBCs and normoblasts of WT and homozygous {Delta}HS-62.5, {Delta}3'HS1 cells (Table 3). Thus, the flanking HSs are not necessary to prevent gene silencing associated with terminal erythroid maturation. In addition, while the lack of transcriptional phenotype in heterozygous cells could be explained by pairing with, or complementation by, the WT allele (ie, transvection), the normal transcription pattern observed in these homozygous mutant cells rules out this potential explanation. In contrast to definitive erythropoiesis, primitive erythropoiesis is marked by a high proportion of long-lived circulating nucleated RBCs, many of which show active transcription of the Ey gene.43 To determine if the flanking HSs act to ensure transcription during primitive erythropoiesis, 100 cell pools of circulating cells were isolated from embryos 10.5 days after conception, and expression of the embryonic Ey gene was analyzed by RT-PCR. The ratio of expression from the mutant D allele to the WT S allele was 1.1 ± 0.05, similar to that observed in control animals. Finally, the flanking elements may protect the locus during stress erythropoiesis, when high rates of transcription in the context of altered patterns of cell division may affect the content of histone modifications and gene expression. To address this, heterozygous mutant {Delta}HS-62.5, {Delta}3'HS1-D/S, and control WT-D/S mice were analyzed during recovery from a phenylhydrazine-induced hemolytic anemia. Adult beta-globin gene expression in peripheral blood and spleen (the major site of erythropoietic response to acute anemic stress) was analyzed by allele-specific quantitative RT-PCR. No significant difference was detected in the ratio of expression of the mutant D allele to the control S allele when compared with that obtained in WT heterozygotic controls (Table 4). Thus, these flanking HSs are not necessary for protecting the locus from silencing during acute erythropoietic stress.


View this table:
[in this window]
[in a new window]
 
Table 3.. Active beta-major transcription in orthochromatic normoblasts and nucleated RBCs as determined by primary transcript RNA FISH

 


View this table:
[in this window]
[in a new window]
 
Table 4.. Adult beta-globin expression in erythroid tissues during stress erythropoiesis

 
Although we removed the regions in which the flanking HSs form, it is formally possible that sequences outside of our deletions dictate HS formation, or that redundant sequence elements lead to formation of new HSs. To determine if HSs form in the region of our targeted deletions, DNaseI HSs were mapped in erythroid tissue of WT and homozygous {Delta}HS-62.5, {Delta}3'HS1 mice. Figure 3 shows that while characteristic HSs form in the WT mice, no HSs form within several kilobases of the HS-62.5 or 3'HS1 deletions in mutant mice. Rehybridization of the {Delta}HS-62.5, {Delta}3'HS1 blots demonstrates normal formation of 5'HS4 of the LCR; thus, this lack of flanking HS formation is not a result of inadequate DNaseI digestion conditions.


    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Heterozygous D/S-2B and {Delta}LCR-D/S-1 ES cells facilitate the in vitro analysis of targeted beta-globin locus mutations

Previously, in vitro assessment of the transcriptional phenotype of beta-globin mutations was dependent on the generation of homozygous mutations and relied on comparison to external reference genes. In addition, the effects of passage through the germ line were not known. The use of ES cells heterozygous for the HbbS (S) and HbbD (D) alleles allows quantitative comparison of transcriptional output from the mutant D allele compared with the wild-type control S allele on a per-cell basis throughout differentiation. Here we show that after in vitro differentiation the transcriptional phenotype of several mutant beta-globin alleles parallels those seen in vivo. This is true for mutations that lead to no effect, or reduce expression to 3% to 5% of normal. In addition, using D/S-2B cells, we recently demonstrated that large, or core, deletions of 5'HS2 result in a 20% to 30% reduction in expression whether analyzed in vitro or in vivo.44 Thus, several mutations, displaying a wide range of severity, each have the same transcriptional phenotype in vitro as in vivo. While we cannot rule out subtle differences in the level of transcription or in globin gene switching, we have validated in vitro differentiation as a screening technique. The generation of ES-cell–derived erythroid progenitor lines (ES-EPs) with tremendous proliferative potential45 from these cell lines will further extend the potential for this approach by facilitating the attainment of sufficient cells to allow internally controlled chromatin immunoprecipitations and 3C analysis.

The Hispanic thalassemia phenotype may reflect chromosomal history

The deletion of the LCR from the endogenous mouse or human locus results in decreased expression, but not the profound heterochromatization and transcriptional silencing observed for the Hispanic thalassemia beta-globin locus. To determine whether additional upstream sequences deleted in the Hispanic chromosome (UHR) were responsible for this discrepancy, we extended the deletion of the mouse LCR to remove all sequences homologous to those deleted in the Hispanic deletion in the human locus, as well as the conserved HS-62.5 region. Compared with the deletion of the LCR, deletion of this additional 35 kb did not further affect transcription when examined in bulk or in single cells. Thus, the UHR does not contribute to the LCR-independent basal transcription observed previously. Although we cannot formally rule out the possibility that the UHR may possess transcriptional regulatory activity, our results suggest that any such activity is dependent on the LCR or elements therein.

There are several possible explanations as to why excising all homology with the Hispanic deletion does not recapitulate the Hispanic phenotype. Inherent differences between the mouse and human chromosomes, and our not faithfully replicating the breakpoints of the Hispanic deletion are unlikely, as regenerating the Hispanic deletion in a human chromosome 11 transfer system silences transcription, but the nondeleted HSs (eg, 3'HS1) form normally (A. Reik and M.G., unpublished observation, December 1999). While cross-species effects cannot be ruled out, we believe it is more likely that the discrepancy in observed phenotype is a function of the cellular history of the Hispanic chromosome. The studies demonstrating that the Hispanic deletion resulted in heterochromatinization of the beta-globin locus were performed after transfer of the patient's chromosomes from Epstein-Barr virus (EBV)–transformed lymphoblasts into MEL cells.4 After transfer from lymphoid to MEL cells the beta-globin locus on the patient's wild-type chromosome 11 is in a DNaseI-sensitive conformation, is expressed in an inducible manner, and replicates early in S-phase using the normal replication origin. In marked contrast, the beta-globin locus on the Hispanic allele, transferred in parallel, is DNaseI resistant, is transcriptionally silent, and replicates late in S-phase using an alternate origin. Prolonged passage of the Hispanic chromosome in an erythroid environment, and treatment with demethylating agents and histone deacetylase inhibitors have not altered this phenotype (Chul G. Kim, unpublished observations, February 1991). Thus, the Hispanic deletion may leave the beta-globin locus uniquely susceptible to epigenetic modifications in a lymphoid environment that leads to irreversible gene silencing. The LCR alone or in combination with upstream sequences may protect the locus from such stable modifications in nonerythroid environments. Notably, beta-globin LCR HS formation has been described in lymphoid cell lines,46 which could reflect a state whereby the locus is protected from irreversible silencing. This may have important implications for chromosome and nuclear transfer experiments where epigenetic modifications occurring in one cellular background may profoundly effect gene regulation after transfer, particularly on chromosomes with alterations in elements implicated in regulating gene expression.


Figure 3
View larger version (116K):
[in this window]
[in a new window]
 
Figure 3.. Mapping of DNaseI HSs in the HS-62.5 and 3'HS1 regions of WT and {Delta}HS-62.5, {Delta}3'HS1 mice. DNaseI series from WT and homozygous mutant mice were digested with EcoRV and hybridized with probes to the 3' end of each restriction fragment. After hybridization to HS-62.5 or 3'HS1 region probes, blots from mutant mice were stripped and rehybridized to a probe to the 5'HS4 region to demonstrate the quality of the DNase series. The edge of a 1-kb marker lane is observed on the far left. DNaseI digestion increases from left to right. The characteristic doublet of HSs for the HS-62.5 and 3'HS1 regions in WT samples are marked by arrows (left blots). The characteristic doublet of 5'HS4 is marked by arrows (right blots). An asterisk marks the size of expected fragments if a HS formed at the site of the targeted deletions in mutant samples (middle blots). Left blots are from WT mice. Middle and right blots are from homozygous {Delta}HS-62.5, {Delta}3'HS1 mice. Probes used are indicated above each panel.

 
Deletion of the flanking HSs has no affect on transcription

This is the first deletional, or loss-of-function, analysis of HSs flanking an endogenous beta-globin locus and LCR. A seminal question in globin gene regulation is what prevents silencing of the locus during erythroid differentiation. It has been hypothesized that barrier elements flank the locus, protecting it from the encroachment of heterochromatin.22 Suggestions that HS-62.5 and 3'HS1 regions might be involved in preventing silencing of the locus comes from (1) sequence conservation between mouse and human; (2) conserved organization of these regions between species as disparate as mouse and chicken, in which these elements flank the LCR and genes of the locus and reside near the transition from DNase-sensitive to -resistant chromatin; and (3) studies of the well-characterized chicken beta-globin locus. In the chicken, the flanking HSs mark an abrupt change in chromatin structure and presumably protect the locus from the spread of the surrounding heterochromatin while preventing the inadvertent activation of neighboring genes.25,26,29 Prior studies defining the activities of the c5'HS4 and 3'HS elements were performed using ectopic integration sites and demonstrated that while both elements have CTCF-dependent enhancer-blocking activity, only cHS4 has barrier activity, and this is dependent on binding of USF proteins.21,32,47 Notably, the HSs flanking the murine beta-globin locus have multiple features similar to those flanking the chicken locus. Both HS-62.5 and 3'HS1 in the mouse bind CTCF, and 3'HS1 has enhancer-blocking activity.15 In addition, consistent with the suggestion that 3'HS1 may function as a boundary element, mouse 3'HS1 contains a USF consensus sequence (CACGTG) similar to c5'HS4 (data not shown). Although the phenotype of deleting the chicken elements in the context of the endogenous locus has not been determined, we observe no effect on the accumulation of stable beta-globin transcripts upon deleting either, or both flanking HS regions from the endogenous mouse locus. We have addressed the hypothesis that these flanking HSs are important in preventing silencing during the terminal stages of erythroid maturation, and see no effect on nascent transcripts along the beta-major gene in erythroid cells just prior to enucleation. Thus, we find no evidence that the flanking HSs protect the locus from heterochromatinization as hypothesized for the chicken locus. Similarly, we see no effect on transcription in response to acute erythropoietic stress upon deleting these HSs. There are several possibilities for this lack of transcriptional phenotype.

Functional redundancy. We cannot exclude the possibility that additional CTCF- and/or USF-binding sites, or additional elements that could substitute for the deleted regions, exist elsewhere in the locus. Of note, upon deletion of the HS-62.5 and 3'HS1 regions, no new HSs form within several kilobases of the deletion site. In addition, a gross rearrangement of the locus, deletion of the flanking HSs coupled with inversion of the entire region between them (LCR and genes), does not significantly affect transcription when assayed after ES differentiation in vitro (M.A.B., unpublished observation, January 2001). Taken together, these observations argue that if these elements have a critical function in erythroid cells, there is little stringency for their placement or context.

Divergent evolution. The flanking HSs may have a minimal or no role in the regulation of the mammalian beta-globin locus. In mammals adult nucleated RBCs have a short half-life, and there is only a brief window of development when primitive, nucleated RBCs are essential. In contrast, in adult avian erythropoiesis red cells remain nucleated. Thus, there may be selective pressure in the chicken to protect the beta-globin locus from becoming incorporated into heterochromatin, while in mammals, with enucleated RBCs, this selective pressure has been lost. Consistent with this, analysis using pipmaker48 reveals that although there is homology between mouse and human 3'HS1, it is less than that observed for the LCR HSs and beta-like genes.49

The primary role of these elements is in nonerythroid cells. Although we cannot rule this out, homozygous {Delta}HS-62.5, {Delta}3'HS1 mice have no apparent phenotype and grow and breed normally. The beta-globin locus resides within an array of olfactory receptor genes (ORGs), raising the question of whether these elements are required to insulate the surrounding ORGs from the effects of the LCR.49 This is unlikely, as normally regulated ORGs lie between the LCR and HS-62.5.

The role of the flanking HSs is limited to physiologic states yet to be identified. Regardless of the explanation for the lack of observed phenotype after deleting HS-62.5 and 3'HS1 from the endogenous beta-globin locus in vivo, this finding has implications for current models for globin gene regulation.

Implications for models of chromatin structure

The lack of a detectable transcriptional phenotype and the presence of a normal erythroid cell size demonstrate that any potential change in chromatin structure or spatial conformation of the locus associated with deletion of the flanking HSs has little functional relevance to globin gene expression and hemoglobin accumulation. This has implications for both barrier element and chromatin hub (CH) models regarding the function of the flanking HSs. The CH model suggests 3 CTCF-containing elements (the 2 flanking HSs and 5' end of the LCR) interact to create an erythroid-specific, developmentally stable nuclear compartment designated the core CH.18 It has been hypothesized that this core CH acts as an enzyme, facilitating a proximity-dependent activation of gene expression by the LCR in a structure designated the active CH (ACH).17-20 Here we demonstrate that at the endogenous locus, the absence of 2 of the 3 defined components of the core CH has no effect on transcription. As suggested for human transgenes containing the beta-globin locus, the dispensability of the flanking HSs may be due to redundancy,19 but as noted in "Functional redundancy," this would suggest that the requirements for sequence and positioning are not stringent. Alternatively, the colocalizations detected by 3C may have little functional importance in mammalian erythropoiesis but may rather reflect low frequency or nonspecific juxtaposition. A barrier element model would predict that deletion of the flanking HSs would lead to heterochromatinization and eventual silencing of the locus, yet we find no transcriptional phenotype associated with excision of both flanking HSs. This includes no effect on transcription in the terminal phases of maturation just prior to enucleation, when most genes are silenced, presumably due to incorporation into heterochromatin. While this could be related to functional redundancy, alternatively, the lack of transcriptional phenotype could be explained by these HSs not having a role in chromatin regulation in mammals. Predictions from barrier element models in the chicken may not be relevant to mammals because the loci may not be truly orthologous.15 Differences in the inherited gene duplication products of an ancestral beta-globin gene, the organization of the locus with respect to flanking genes with divergent expression patterns, and differences in histone modifications of the surrounding regions suggest chicken and mammalian loci may have evolved in different contexts; thus, there may be a different role, if any, for the flanking HSs in the different phylogenetic classes.

In summary, although the 5 strains of mice described here harboring deletions of the UHR, HS-62.5 region, 3'HS1, and combinations thereof do not define functional roles for these regions, these results do bring into question several prominent models of beta-globin locus domain regulation and suggest models where the primary determinants of an open, active mammalian beta-globin locus are the genes themselves, and the flanking elements function primarily in a limited, yet undefined context.


    Acknowledgements
 
We thank Oliver Smithies for the gift of BK-4 ES cells, Arthur Sytkowski for the antibody ERY-1, and the Fred Hutchison Cancer Research Center (FHCRC) flow cytometry, image analysis, and transgenic core facilities for assistance. We thank Tomo Sawado and Tony Krumm for review of the manuscript.


    Footnotes
 
Submitted April 3, 2006; accepted April 14, 2006.

Prepublished online as Blood First Edition Paper, April 27, 2006; DOI 10.1182/blood-2006-04-014431.

Supported by National Institutes of Health grant DK44746 (M.G.), American Society of Hematology Scholar Award, and Cooley's Anemia Foundation Award (M.A.B.). M.B. is supported by a Career Award from the Burroughs Wellcome Fund.

M.A.B. designed research, performed research, analyzed data, and wrote the paper; R.B. performed research and analyzed data; T.R. performed research and analyzed data; A.T. performed research and analyzed data; M.B. contributed vital reagents, designed research, and wrote the paper; and M.G. designed research and wrote the paper.

An Inside Blood analysis of this article appears at the front of this issue.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.

Reprints: M. A. Bender, Fred Hutchinson Cancer Research Center, Mailstop D5-390, 1100 Fairview Ave N., Seattle, WA 98109; e-mail: mbender{at}fhcrc.org; or Mark Groudine, Fred Hutchinson Cancer Research Center, Mailstop A3-025, 1100 Fairview Ave N, Seattle, WA 98109; e-mail: markg{at}fhcrc.org.


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 

  1. Stamatoyannopoulos G, Nienhus AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhus AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases (2nd ed). Philadelphia, PA: Saunders; 1994: 107-155.

  2. Curtin P, Pirastu M, Kan YW, Gobert-Jones JA, Stephens AD, Lehmann H. A distant gene deletion affects beta-globin gene function in an atypical gamma delta beta-thalassemia. J Clin Invest. 1985;76: 1554-1558.[Medline] [Order article via Infotrieve]

  3. Driscoll MC, Dobkin CS, Alter BP. Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites. Proc Natl Acad Sci U S A. 1989;86: 7470-7474.[Abstract/Free Full Text]

  4. Forrester WC, Epner E, Driscoll MC, et al. A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. Genes Dev. 1990;4: 1637-1649.[Abstract/Free Full Text]

  5. Taramelli R, Kioussis D, Vanin E, et al. Gamma delta beta-thalassaemias 1 and 2 are the result of a 100 kbp deletion in the human beta-globin cluster. Nucleic Acids Res. 1986;14: 7017-7029.[Abstract/Free Full Text]

  6. Aladjem MI, Groudine M, Brody LL, et al. Participation of the human beta-globin locus control region in initiation of DNA replication. Science. 1995;270: 815-819.[Abstract/Free Full Text]

  7. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell. 1987;51: 975-985.[CrossRef][Medline] [Order article via Infotrieve]

  8. Ryan TM, Behringer RR, Martin NC, Townes TM, Palmiter RD, Brinster RL. A single erythroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice. Genes Dev. 1989;3: 314-323.[Abstract/Free Full Text]

  9. Bulger M, Groudine M. Looping versus linking: toward a model for long-distance gene activation. Genes Dev. 1999;13: 2465-2477.[Free Full Text]

  10. Hardison R, Slightom JL, Gumucio DL, Goodman M, Stojanovic N, Miller W. Locus control regions of mammalian beta-globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insights. Gene. 1997;205: 73-94.[CrossRef][Medline] [Order article via Infotrieve]

  11. Bender MA, Bulger M, Close J, Groudine M. Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol Cell. 2000;5: 387-393.[CrossRef][Medline] [Order article via Infotrieve]

  12. Epner E, Reik A, Cimbora D, et al. The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus. Mol Cell. 1998;2: 447-455.[CrossRef][Medline] [Order article via Infotrieve]

  13. Reik A, Telling A, Zitnik G, Cimbora D, Epner E, Groudine M. The locus control region is necessary for gene expression in the human beta-globin locus but not the maintenance of an open chromatin structure in erythroid cells. Mol Cell Biol. 1998;18: 5992-6000.[Abstract/Free Full Text]

  14. Bulger M, Bender MA, van Doorninck JH, et al. Comparative structural and functional analysis of the olfactory receptor genes flanking the human and mouse beta-globin gene clusters. Proc Natl Acad Sci U S A. 2000;97: 14560-14565.[Abstract/Free Full Text]

  15. Bulger M, Schubeler D, Bender MA, et al. A complex chromatin landscape revealed by patterns of nuclease sensitivity and histone modification within the mouse beta-globin locus. Mol Cell Biol. 2003;23: 5234-5244.[Abstract/Free Full Text]

  16. Farrell CM, West AG, Felsenfeld G. Conserved CTCF insulator elements flank the mouse and human beta-globin loci. Mol Cell Biol. 2002;22: 3820-3831.[Abstract/Free Full Text]

  17. de Laat W, Grosveld F. Spatial organization of gene expression: the active chromatin hub. Chromosome Res. 2003;11: 447-459.[CrossRef][Medline] [Order article via Infotrieve]

  18. Palstra RJ, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, de Laat W. The beta-globin nuclear compartment in development and erythroid differentiation. Nat Genet. 2003;35: 190-194.[CrossRef][Medline] [Order article via Infotrieve]

  19. Patrinos GP, de Krom M, de Boer E, et al. Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes Dev. 2004;18: 1495-1509.[Abstract/Free Full Text]

  20. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell. 2002;10: 1453-1465.[CrossRef][Medline] [Order article via Infotrieve]

  21. Bell AC, Felsenfeld G. Stopped at the border: boundaries and insulators. Curr Opin Genet Dev. 1999;9: 191-198.[CrossRef][Medline] [Order article via Infotrieve]

  22. Burgess-Beusse B, Farrell C, Gaszner M, et al. The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci U S A. 2002;99: 16433-16437.[Abstract/Free Full Text]

  23. Labrador M, Corces VG. Setting the boundaries of chromatin domains and nuclear organization. Cell. 2002;111: 151-154.[CrossRef][Medline] [Order article via Infotrieve]

  24. West AG, Gaszner M, Felsenfeld G. Insulators: many functions, many mechanisms. Genes Dev. 2002;16: 271-288.[Free Full Text]

  25. Hebbes TR, Clayton AL, Thorne AW, Crane-Robinson C. Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J. 1994;13: 1823-1830.[Medline] [Order article via Infotrieve]

  26. Litt MD, Simpson M, Recillas-Targa F, Prioleau MN, Felsenfeld G. Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J. 2001;20: 2224-2235.[CrossRef][Medline] [Order article via Infotrieve]

  27. Reitman M, Felsenfeld G. Developmental regulation of topoisomerase II sites and DNase I-hypersensitive sites in the chicken beta-globin locus. Mol Cell Biol. 1990;10: 2774-2786.[Abstract/Free Full Text]

  28. Saitoh N, Bell AC, Recillas-Targa F, et al. Structural and functional conservation at the boundaries of the chicken beta-globin domain. EMBO J. 2000;19: 2315-2322.[CrossRef][Medline] [Order article via Infotrieve]

  29. Chung JH, Whiteley M, Felsenfeld G. A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell. 1993; 74: 505-514.[CrossRef][Medline] [Order article via Infotrieve]

  30. Pikaart MJ, Recillas-Targa F, Felsenfeld G. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev. 1998;12: 2852-2862.[Abstract/Free Full Text]

  31. Recillas-Targa F, Pikaart MJ, Burgess-Beusse B, et al. Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc Natl Acad Sci U S A. 2002;99: 6883-6888.[Abstract/Free Full Text]

  32. West AG, Huang S, Gaszner M, Litt MD, Felsenfeld G. Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Mol Cell. 2004;16: 453-463.[CrossRef][Medline] [Order article via Infotrieve]

  33. Bulger M, Sawado T, Schubeler D, Groudine M. ChIPs of the beta-globin locus: unraveling gene regulation within an active domain. Curr Opin Genet Dev. 2002;12: 170-177.[CrossRef][Medline] [Order article via Infotrieve]

  34. Bender MA, Reik A, Close J, et al. Description and targeted deletion of 5' hypersensitive site 5 and 6 of the mouse beta-globin locus control region. Blood. 1998;92: 4394-4403.[Abstract/Free Full Text]

  35. Fiering S, Epner E, Robinson K, et al. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev. 1995;9: 2203-2213.[Abstract/Free Full Text]

  36. Schubeler D, Groudine M, Bender MA. The murine beta-globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc Natl Acad Sci U S A. 2001;98: 11432-11437.[Abstract/Free Full Text]

  37. Kina T, Ikuta K, Takayama E, et al. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000;109: 280-287.[CrossRef][Medline] [Order article via Infotrieve]

  38. Bacon ER, Sytkowski AJ. Identification and characterization of a differentiation-specific antigen on normal and malignant murine erythroid cells. Blood. 1987;69: 103-108.[Abstract/Free Full Text]

  39. Ragoczy T, Bender MA, Telling A, Byron R, Groudine M. The murine beta-globin LCR positions the globin locus at engaged transcription factories during erythroid maturation. Genes Dev. 2006;20: 1447-1457.[Abstract/Free Full Text]

  40. Hooper M, Hardy K, Handyside A, Hunter S, Monk M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature. 1987;326: 292-295.[CrossRef][Medline] [Order article via Infotrieve]

  41. Abbondanzo SJ, Gadi I, Stewart CL. Derivation of embryonic stem cell lines. Methods Enzymol. 1993;225: 803-823.[Medline] [Order article via Infotrieve]

  42. Nakano T, Era T, Takahashi T, Kodama H, Honjo T. Development of erythroid cells from mouse embryonic stem cells in culture: potential use for erythroid transcription factor study. Leukemia. 1997;11: 496-500.[Medline] [Order article via Infotrieve]

  43. Trimborn T, Gribnau J, Grosveld F, Fraser P. Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci. Genes Dev. 1999;13: 112-124.[Abstract/Free Full Text]

  44. Hu X, Bulger M, Bender MA, Fields J, Groudine M, Fiering S. Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes. Blood. 2006;107: 821-826.[Abstract/Free Full Text]

  45. Carotta S, Pilat S, Mairhofer A, et al. Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood. 2004;104: 1873-1880.[Abstract/Free Full Text]

  46. Dhar V, Nandi A, Schildkraut CL, Skoultchi AI. Erythroid-specific nuclease-hypersensitive sites flanking the human beta-globin domain. Mol Cell Biol. 1990;10: 4324-4333.[Abstract/Free Full Text]

  47. Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell. 1999;98: 387-396.[CrossRef][Medline] [Order article via Infotrieve]

  48. Schwartz S, Zhang Z, Frazer KA, et al. PipMaker—a web server for aligning two genomic DNA sequences. Genome Res. 2000;10: 577-586.[Abstract/Free Full Text]

  49. Bulger M, van Doorninck JH, Saitoh N, et al. Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes [published erratum appears in Proc Natl Acad Sci U S A. 1999;96:8307]. Proc Natl Acad Sci U S A. 1999;96: 5129-5134.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

A lack of border guards?
William G. Wood and Douglas R. Higgs
Blood 2006 108: 1121. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Brief Funct Genomic ProteomicHome page
R.-J. Theo Sijtse Palstra
Close encounters of the 3C kind: long-range chromatin interactions and transcriptional regulation
Brief Funct Genomic Proteomic, June 17, 2009; (2009) elp016v1.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
X. Zhang, S. A. Horrell, D. Delaney, and D. I. Gottlieb
Embryonic Stem Cells as a Platform for Analyzing Neural Gene Transcription
Stem Cells, July 1, 2008; 26(7): 1841 - 1849.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Singh and M. Srivastava
Enhancer Blocking Activity of the Insulator at H19-ICR Is Independent of Chromatin Barrier Establishment
Mol. Cell. Biol., June 1, 2008; 28(11): 3767 - 3775.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kooren, R.-J. Palstra, P. Klous, E. Splinter, M. von Lindern, F. Grosveld, and W. de Laat
beta-Globin Active Chromatin Hub Formation in Differentiating Erythroid Cells and in p45 NF-E2 Knock-out Mice
J. Biol. Chem., June 1, 2007; 282(22): 16544 - 16552.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Kim, C. M. Kiefer, and A. Dean
Distinctive Signatures of Histone Methylation in Transcribed Coding and Noncoding Human {beta}-Globin Sequences
Mol. Cell. Biol., February 15, 2007; 27(4): 1271 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J. Dostie, T. A. Richmond, R. A. Arnaout, R. R. Selzer, W. L. Lee, T. A. Honan, E. D. Rubio, A. Krumm, J. Lamb, C. Nusbaum, et al.
Chromosome Conformation Capture Carbon Copy (5C): A massively parallel solution for mapping interactions between genomic elements
Genome Res., October 1, 2006; 16(10): 1299 - 1309.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-014431v1
108/4/1395    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bender, M. A.
Right arrow Articles by Groudine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bender, M. A.
Right arrow Articles by Groudine, M.
Related Collections
Right arrow Red Cells
Right arrow Gene Expression
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020